Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatma Nabli

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cells|April 23, 2022
B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's DiseaseOlfa Maghrebi, Meriam Belghith, Cyrine Jeridi, et al.
Journal of Neurogenetics|December 18, 2023
Genetic heterogeneity within a consanguineous family involving <i>TTPA</i> and <i>SETX</i> genesCyrine Jeridi, Amine Rachdi, Fatma Nabli, et al.
Parkinsonism & Related Disorders|November 8, 2011
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's diseaseSamia Ben Sassi, Fatma Nabli, Emna Hentati, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 1, 2012
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian familiesMonia Benhamed Hammer, Ghada El Euch-Fayache, Houda Nehdi, et al.
Neurobiology of Aging|December 21, 2013
Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismJoanne Trinh, Rim Amouri, John E Duda, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2019
Stroke in the Middle-East and North Africa: A 2-year prospective observational study of stroke characteristics in the region-Results from the Safe Implementation of Treatments in Stroke (SITS)-Middle-East and North African (MENA)Suhail Al Rukn, Michael V Mazya, Faycal Hentati, et al.
The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cells|April 23, 2022
B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's DiseaseOlfa Maghrebi, Meriam Belghith, Cyrine Jeridi, et al.
Journal of Neurogenetics|December 18, 2023
Genetic heterogeneity within a consanguineous family involving <i>TTPA</i> and <i>SETX</i> genesCyrine Jeridi, Amine Rachdi, Fatma Nabli, et al.
Parkinsonism & Related Disorders|November 8, 2011
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's diseaseSamia Ben Sassi, Fatma Nabli, Emna Hentati, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 1, 2012
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian familiesMonia Benhamed Hammer, Ghada El Euch-Fayache, Houda Nehdi, et al.
Neurobiology of Aging|December 21, 2013
Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismJoanne Trinh, Rim Amouri, John E Duda, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2019
Stroke in the Middle-East and North Africa: A 2-year prospective observational study of stroke characteristics in the region-Results from the Safe Implementation of Treatments in Stroke (SITS)-Middle-East and North African (MENA)Suhail Al Rukn, Michael V Mazya, Faycal Hentati, et al.
The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.
Pageof 2